LP

Lion Point Capital, LP

Sector-focusedMomentum followerQuality / disciplined sizing

Total reported value

$16.7M

Reporting period: 2026-03-31 · Number of holdings: 35

Lion Point Capital, LP disclosed 35 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $16.7M and a quarterly turnover rate of 26.9%.

Personality snowflake

Concentration
16.65
Portfolio Stability
26.95
Momentum/Contrarian
100
Sector conviction
100
Diversification
70
Sizing Uniformity
93.14

Recent moves

  • Add MLTX

    0.0%　$368.6K

  • Trim MIST

    +8.6%　-$549.3K

  • Trim JSPR

    0.0%　-$443.5K

  • Add RPRX

    0.0%　$199.7K

  • Add PRAX

    0.0%　$122.2K

  • Add GERN

    0.0%　$98.3K

Holdings Map

New buyAddUnchangedTrim

Top 10 holdings by weight

Full holdings list this quarter

#TickerIssuerAsset SubclassWeightWeight ChangeShares Change4Q Trend
1PRAXPraxis Precision Medicines IStock-Other8.57%+1.78%—
2MLTXMoonlake ImmunotherapeuticsStock-Other7.52%+2.92%—
3RPRXRoyalty Pharma plcStock-Healthcare6.14%+1.86%—
4MISTMilestone Pharmaceuticals InStock-Other5.83%-2.06%+8.61%
5GERNGeron CORPStock-Other5.15%+1.20%—
6SNDXSyndax Pharmaceuticals INCStock-Other5.03%+1.12%—
7ARDXArdelyx INCStock-Other4.61%+0.73%—
8FENCFennec Pharmaceuticals INCStock-Other4.13%-0.35%—
9BNTCBenitec Biopharma INCStock-Other3.95%-0.37%—
10SRPTSarepta Therapeutics INCStock-Healthcare3.71%+0.54%—
11IRONDisc Medicine INCStock-Other3.10%-0.23%—
12CUE1EURCue Biopharma INCStock-Other3.03%-0.45%—
13CMPSCompass Pathways PLCStock-Other2.64%+0.57%+37.93%
14BHVNBiohaven Ltd.Stock-Other2.61%-0.41%—
15LNTHLantheus Holdings INCStock-Healthcare2.49%+0.60%—
16JSPRJasper Therapeutics INCStock-Other2.44%-1.96%—
17HUMAHumacyte INCStock-Other2.36%-0.13%+30.00%
18VTRSViatris INCStock-Healthcare2.24%+0.46%—
19KURAKura Oncology INCStock-Other2.24%-0.23%—
20BBIOBridgebio Pharma INCStock-Healthcare2.22%+0.24%—
21DYNDyne Therapeutics INCStock-Other1.95%+0.13%—
22RCKTRocket Pharmaceuticals INCStock-Other1.84%+0.28%—
23PCRXPacira Biosciences INCStock-Other1.82%+0.01%—
24EWTXEdgewise Therapeutics INCStock-Other1.71%+0.54%—
25MLYSMineralys Therapeutics INCStock-Other1.70%-0.27%—
26MCRBSeres Therapeutics INCStock-Other1.67%-0.76%—
27JANXJanux Therapeutics INCStock-Other1.58%+0.22%—
28QUREuniQure N.V.Stock-Other1.44%-0.38%—
29RGNXRegenxbio INCStock-Other1.33%-0.65%—
30AZTAAzenta INCStock-Other1.22%-0.44%—
31INVAInnoviva INCStock-Other1.14%+0.29%—
32GHRSGH Research PLCStock-Other0.86%+0.19%—
33ARQTArcutis Biotherapeutics INCStock-Other0.74%-0.05%—
34IPHAInnate Pharma Sa-spons AdrStock-Other0.62%-0.11%—
35SPRBSpruce Biosciences INCStock-Other0.39%-0.06%—

Holding changes this quarter

Lion Point Capital, LP's most significant position changes for 2026-03-31: Sold out: Day One Biopharmaceuticals I (DAWNGBX); Sold out: Ventyx Biosciences INC (VTYXUSD); Sold out: Minerva Neurosciences INC (NERV); Sold out: Mersana Therapeutics INC (MRSN); Add: Milestone Pharmaceuticals In (MIST) — shares +8.61%.

Position changes disclosed by Lion Point Capital, LP for the quarter ending 2026-03-31, including ticker, issuer, weight change, shares change, and action
#TickerIssuerWeight ChangeShares ChangeAction
1MLTXMoonlake Immunotherapeutics+2.9%—Unchanged
2RPRXRoyalty Pharma plc+1.9%—Unchanged
3PRAXPraxis Precision Medicines I+1.8%—Unchanged
4GERNGeron CORP+1.2%—Unchanged
5SNDXSyndax Pharmaceuticals INC+1.1%—Unchanged
6ARDXArdelyx INC+0.7%—Unchanged
7LNTHLantheus Holdings INC+0.6%—Unchanged
8CMPSCompass Pathways PLC+0.6%+37.93%Add
9EWTXEdgewise Therapeutics INC+0.5%—Unchanged
10SRPTSarepta Therapeutics INC+0.5%—Unchanged
11VTRSViatris INC+0.5%—Unchanged
12INVAInnoviva INC+0.3%—Unchanged
13RCKTRocket Pharmaceuticals INC+0.3%—Unchanged
14BBIOBridgebio Pharma INC+0.2%—Unchanged
15JANXJanux Therapeutics INC+0.2%—Unchanged
16GHRSGH Research PLC+0.2%—Unchanged
17DYNDyne Therapeutics INC+0.1%—Unchanged
18PCRXPacira Biosciences INC0%—Unchanged
19ARQTArcutis Biotherapeutics INC-0.1%—Unchanged
20SPRBSpruce Biosciences INC-0.1%—Unchanged
21IPHAInnate Pharma Sa-spons Adr-0.1%—Unchanged
22HUMAHumacyte INC-0.1%+30.00%Add
23IRONDisc Medicine INC-0.2%—Unchanged
24KURAKura Oncology INC-0.2%—Unchanged
25MLYSMineralys Therapeutics INC-0.3%—Unchanged
26FENCFennec Pharmaceuticals INC-0.4%—Unchanged
27BNTCBenitec Biopharma INC-0.4%—Unchanged
28QUREuniQure N.V.-0.4%—Unchanged
29BHVNBiohaven Ltd.-0.4%—Unchanged
30AZTAAzenta INC-0.4%—Unchanged
31CUE1EURCue Biopharma INC-0.5%—Unchanged
32RGNXRegenxbio INC-0.7%—Unchanged
33MCRBSeres Therapeutics INC-0.8%—Unchanged
34JSPRJasper Therapeutics INC-2%—Unchanged
35MISTMilestone Pharmaceuticals In-2.1%+8.61%Add
36DAWNGBXDay One Biopharmaceuticals I—EXITSold out
37VTYXUSDVentyx Biosciences INC—EXITSold out
38NERVMinerva Neurosciences INC—EXITSold out
39MRSNMersana Therapeutics INC—EXITSold out

FAQ

What is Lion Point Capital, LP and what type of investor is it?
Lion Point Capital, LP is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2026-03-31), the firm manages a tracked equity portfolio valued at approximately $16.7M, spread across 35 disclosed positions.
What are Lion Point Capital, LP's largest equity positions?
Based on the latest 13F filing, Lion Point Capital, LP's top holdings by market value are: 1. Praxis Precision Medicines I (PRAX) — $1.4M (8.6%) 2. Moonlake Immunotherapeutics (MLTX) — $1.3M (7.5%) 3. Royalty Pharma plc (RPRX) — $1.0M (6.1%) 4. Milestone Pharmaceuticals In (MIST) — $975.8K (5.8%) 5. Geron CORP (GERN) — $861.2K (5.2%)
What changes did Lion Point Capital, LP make in its most recent portfolio filing?
In the latest reported quarter, Lion Point Capital, LP made 7 notable position adjustments: 0 new positions were initiated, 3 existing holdings were added to, 0 positions were partially reduced, and 4 were completely exited. The largest of these moves: Sold out: Day One Biopharmaceuticals I (DAWNGBX); Sold out: Ventyx Biosciences INC (VTYXUSD); Sold out: Minerva Neurosciences INC (NERV); Sold out: Mersana Therapeutics INC (MRSN); Add: Milestone Pharmaceuticals In (MIST) — shares +8.61%
What sectors does Lion Point Capital, LP focus on?
Lion Point Capital, LP is concentrated in the following sectors based on its current disclosed equity portfolio: • Health Care: 100.0%